Skip to main content
Clinical Trials/NCT05031715
NCT05031715UnknownNot Applicable

Effectiveness of the Assumption of a Berberine Phytosoma-based Supplement on the Hematic Values of Glucose in a Group of Patients With Altered Fasting Glucose

Azienda di Servizi alla Persona di Pavia2 sites in 1 country50 target enrollmentStarted: March 2, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
50
Locations
2
Primary Endpoint
Changes on insulin resistance

Study Overview

Brief Summary

The aim of the study was to evaluate the effectiveness of a food supplement, berberine phytosome, which contributes to the control of blood sugar and the improvement of insulin resistance.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Fasting blood glucose range:100-125 mg/dl

Exclusion Criteria

  • Diabetes mellitus

Outcomes

Primary Outcomes

Changes on insulin resistance

Time Frame: Changes from baseline insulin resistance at 4 weeks and at 8 weeks

Homeostasis Model Assessment (pt), for evaluate insulin resistance if \> 2,4

Changes on carbohydrate profile

Time Frame: Changes from baseline carbohydrate profile at 4 weeks and at 8 weeks

Fasting Glucose (mg/dl)

Secondary Outcomes

  • Changes on body composition(Changes from baseline body composition at 4 weeks and at 8 weeks)
  • Changes on lipid profile(Changes from baseline lipid profile at 4 weeks and at 8 weeks)
  • Changes on anthropometry(Changes from baseline anthropometry at 4 weeks and at 8 weeks)
  • Changes on Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability](Changes from baseline Incidence of Treatment-Emergent Adverse Events at 4 weeks and at 8 weeks)

Investigators

Sponsor
Azienda di Servizi alla Persona di Pavia
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials